Shares traded 11.55% lower at $53.30 after the release, according to Benzinga Pro. Adjusted EPS was $0.74, topping the $0.70 consensus, on sales of $303.70 million versus $291.84 million expected. Net earnings rose 45% to $34.8 million and adjusted EBITDA increased 34% to $65.1 million. Operating income reached $9.2 million, reversing a loss a year ago, with adjusted operating income at $11.7 million. The quarter included a 100,000-share buyback for $6.3 million, a $0.19 dividend, and an end-of-period cash balance of $167.1 million, reduced partly by the $91.2 million Elgen purchase.
